Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04855162 · ClinicalTrials.gov registry record
Use of Lung Ultrasound in Evaluating Physiological Response to Awake Self Proning
A clinical trial, sponsored by Rush University Medical Center.
- Completed
- Registry status
- 74
- Enrollment target
NCT04855162: Completed study, sponsored by Rush University Medical Center.
NCT04855162 is a clinical trial that has completed, run by Rush University Medical Center. The registered enrollment target is 74 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04855162 has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- 74 participants
- Enrollment target
Study Summary
The primary objective of this study is to explore the physiological mechanism of awake, self proning among patients with acute hypoxemic respiratory failure induced by COVID-19, using LUS in the first three days and explore the predictive value of LUS in patients' outcome.
Primary Outcome
Patients' response of oxygenation using SpO2/FiO2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2021-07-21 |
| Est. Completion | 2021-10-23 |
What the finished NCT04855162 record still lists
NCT04855162 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 74 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04855162 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04855162 about?
NCT04855162 is a clinical study titled "Use of Lung Ultrasound in Evaluating Physiological Response to Awake Self Proning". The primary objective of this study is to explore the physiological mechanism of awake, self proning among patients with acute hypoxemic respiratory failure induced by COVID-19, using LUS in the first three days and explore the predictive value of LUS in patients' outcome.
What is the current status of trial NCT04855162?
This trial is currently completed. The enrollment target is 74 participants. The study started on 2021-07-21. Estimated completion is 2021-10-23.
Who is sponsoring clinical trial NCT04855162?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI